Talk:Eugeroic: Difference between revisions

(14 intermediate revisions by 5 users not shown)

Line 1:

'''Eugeroics''' (originally, "eugrégorique" or "eugregoric"),<ref>Milgram, Norton W.; Callahan, Heather; Siwak, Christina (2006). "Adrafinil: A Novel Vigilance Promoting Agent". CNS Drug Reviews. 5 (3): 193–212. doi:10.1111/j.1527-3458.1999.tb00100.x.</ref> also known as wakefulness-promoting agents and wakefulness-promoting drugs, are a class of drugs that promote wakefulness and alertness.<ref name="modaFDA">[https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020717s037s038lbl.pdf "Provigil: Prescribing information" (PDF)]. United States Food and Drug Administration. Cephalon, Inc. January 2015. Retrieved 16 August 2015.</ref><ref name="armodaFDA">[https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021875s021lbledt.pdf "Nuvigil: Prescribing information" (PDF)]. United States Food and Drug Administration. Cephalon, Inc. April 2015. Retrieved 16 August 2015.</ref> They are used medically for the treatment of certain sleeping disorders, such as excessive daytime sleepiness and narcolepsy.<ref name="modaFDA" /><ref name="armodaFDA" /> Unlike traditional stimulants, they generally have a low addictive potential.<ref name="modaFDA" /><ref name="armodaFDA" />

The prototypical and most widely known eugeroic is [[modafinil]]. Other substances in the class include [[armodafinil]], its [[enantiopure]] formulation, and [[adrafinil]], a modafinil [[prodrug]]. Modafinil and armodafinil have been found to act as selective, weak, atypical dopamine reuptake inhibitors.<ref name="modaFDA" /><ref name="armodaFDA" />

==Subjective effects==

These effects are listed and defined in detail within their own dedicated articles below:

*'''[[Wakefulness]]'''

*'''[[Stimulation]]'''

*'''[[Thought acceleration]]'''

Secondary effects include:

*'''[[Focus enhancement]]'''

*'''[[Cognitive euphoria]]'''

*'''[[Memory enhancement]]'''

*'''[[Analysis enhancement]]'''

*'''[[Increased music appreciation]]'''

*'''[[Ego inflation]]'''

*'''[[Time distortion]]''' - This can be described as the experience of time speeding up and passing much quicker than it usually would when sober.

==Examples==

* [[Modafinil]]

* [[Armodafinil]]

* [[Adrafinil]]

* [[Lauflumide]]

==See also==

* [[Stimulants]]

==Literature==

* Engber TM, Koury EJ, Dennis SA, Miller MS, Contreras PC, Bhat RV (January 1998). "Differential patterns of regional c-Fos induction in the rat brain by amphetamine and the novel wakefulness-promoting agent modafinil". Neurosci. Lett. 241 (2-3): 95–8. PMID 9507929. https://doi.org/10.1016/s0304-3940(97)00962-2.

* Darwish, M.; Kirby, M.; Hellriegel, E. T.; Robertson Jr, P. (2009). "Armodafinil and Modafinil Have Substantially Different Pharmacokinetic Profiles Despite Having the Same Terminal Half-Lives". Clinical Drug Investigation. 29 (9): 613–623. PMID 19663523. https://doi.org/10.2165/11315280-000000000-00000.

* Milgram, Norton W.; Callahan, Heather; Siwak, Christina (2006). "Adrafinil: A Novel Vigilance Promoting Agent". CNS Drug Reviews. 5 (3): 193–212. https://doi.org/10.1111/j.1527-3458.1999.tb00100.x.

==External links==

*[[wikipedia:Eugeroic|Eugeroic (Wikipedia)]]

==References==

==Notes==

{{mbox

| type = delete

| image = [[File:Red x.svg|30px|alt=|link=]]

| text = This article neither follows our general article structures nor does it use consistent language as used in other articles. Herewith marked as candidate for removal.

}}

A wakefulness-promoting agent (or wakefulness-promoting drug), also known as a eugeroic (originally "eugrégorique" or "eugregoric"), is a type of drug which specifically improves wakefulness and alertness.

Line 28:

Line 78:

The prototypical eugeroic is modafinil, and others.

[[Category:Approval]]

@@ Line 1: / Line 1: @@
+'''Eugeroics''' (originally, "eugrégorique" or "eugregoric"),<ref>Milgram, Norton W.; Callahan, Heather; Siwak, Christina (2006). "Adrafinil: A Novel Vigilance Promoting Agent". CNS Drug Reviews. 5 (3): 193–212. doi:10.1111/j.1527-3458.1999.tb00100.x.</ref> also known as wakefulness-promoting agents and wakefulness-promoting drugs, are a class of drugs that promote wakefulness and alertness.<ref name="modaFDA">[https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020717s037s038lbl.pdf "Provigil: Prescribing information" (PDF)]. United States Food and Drug Administration. Cephalon, Inc. January 2015. Retrieved 16 August 2015.</ref><ref name="armodaFDA">[https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021875s021lbledt.pdf "Nuvigil: Prescribing information" (PDF)]. United States Food and Drug Administration. Cephalon, Inc. April 2015. Retrieved 16 August 2015.</ref> They are used medically for the treatment of certain sleeping disorders, such as excessive daytime sleepiness and narcolepsy.<ref name="modaFDA" /><ref name="armodaFDA" /> Unlike traditional stimulants, they generally have a low addictive potential.<ref name="modaFDA" /><ref name="armodaFDA" />
+The prototypical and most widely known eugeroic is [[modafinil]]. Other substances in the class include [[armodafinil]], its [[enantiopure]] formulation, and [[adrafinil]], a modafinil [[prodrug]]. Modafinil and armodafinil have been found to act as selective, weak, atypical dopamine reuptake inhibitors.<ref name="modaFDA" /><ref name="armodaFDA" />
+==Subjective effects==
+{{Preamble/SubjectiveEffects}}
+These effects are listed and defined in detail within their own dedicated articles below:
+*'''[[Wakefulness]]'''
+*'''[[Stimulation]]'''
+*'''[[Thought acceleration]]'''
+Secondary effects include:
+*'''[[Focus enhancement]]'''
+*'''[[Cognitive euphoria]]'''
+*'''[[Memory enhancement]]'''
+*'''[[Analysis enhancement]]'''
+*'''[[Increased music appreciation]]'''
+*'''[[Ego inflation]]'''
+*'''[[Time distortion]]''' - This can be described as the experience of time speeding up and passing much quicker than it usually would when sober.
+==Examples==
+* [[Modafinil]]
+* [[Armodafinil]]
+* [[Adrafinil]]
+* [[Lauflumide]]
+==See also==
+* [[Stimulants]]
+==Literature==
+* Engber TM, Koury EJ, Dennis SA, Miller MS, Contreras PC, Bhat RV (January 1998). "Differential patterns of regional c-Fos induction in the rat brain by amphetamine and the novel wakefulness-promoting agent modafinil". Neurosci. Lett. 241 (2-3): 95–8. PMID 9507929. https://doi.org/10.1016/s0304-3940(97)00962-2.
+* Darwish, M.; Kirby, M.; Hellriegel, E. T.; Robertson Jr, P. (2009). "Armodafinil and Modafinil Have Substantially Different Pharmacokinetic Profiles Despite Having the Same Terminal Half-Lives". Clinical Drug Investigation. 29 (9): 613–623. PMID 19663523. https://doi.org/10.2165/11315280-000000000-00000.
+* Milgram, Norton W.; Callahan, Heather; Siwak, Christina (2006). "Adrafinil: A Novel Vigilance Promoting Agent". CNS Drug Reviews. 5 (3): 193–212. https://doi.org/10.1111/j.1527-3458.1999.tb00100.x.
+==External links==
+*[[wikipedia:Eugeroic|Eugeroic (Wikipedia)]]
+==References==
+<references />
+==Notes==
+{{mbox
+| type  = delete
+| image = [[File:Red x.svg|30px|alt=|link=]]
+| text  = This article neither follows our general article structures nor does it use consistent language as used in other articles. Herewith marked as candidate for removal.
+}}
 A wakefulness-promoting agent (or wakefulness-promoting drug), also known as a eugeroic (originally "eugrégorique" or "eugregoric"), is a type of drug which specifically improves wakefulness and alertness.
@@ Line 28: / Line 78: @@
 The prototypical eugeroic is modafinil, and others.
+[[Category:Approval]]